MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET 2021-2028

Lifesciences | Healthcare IT

MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s research report, the Middle East and African digital genome market is anticipated to surge with a CAGR of 6.68% in the forecasting years from 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries reviewed in this market are:

•           Saudi Arabia

•           Turkey

•           South Africa

•           The United Arab Emirates

•           Rest of MEA countries

According to an article, there is a high occurrence of inherited genetic diseases in Saudi Arabia, due to the highly prevalent tradition of consanguineous marriage in the country. When close relatives marry, the risk of parents passing on recessive genetic mutations to their offspring increases significantly. Also, as per a 2015 article in IEEE Pulse, 20% of the children born in the country had genetic diseases like diabetes at the time of birth, and another 8% of these newborns had inherited more severe diseases.

Thus, to look for a solution to this issue prevalent in the Saudi Arabian population, genetic researchers at the King Faisal Specialist Hospital & Research Center (KFSHRC) began started their research on genetic disease. They then implemented a national project, called the Saudi Human Genome Program (SHGP), to study the genetic basis of diseases in the KSA and the Middle East. This program was formally launched at the end of 2013, with an aim to sequence the genomes of 100,000 individuals using targeted next-generation sequencing. Thus, the growing number of studies and researches in genetics in the country are estimated to boost the digital genome market’s growth in Saudi Arabia during the forecast period.

Bio-Rad Laboratories Inc is a specialty chemicals company manufacturing products for biochemical, pharmaceutical, and other life sciences research applications. It provides these products to a range of end-users, such as food producers, government agencies, researchers, industrial research organizations, biotechnology & pharmaceutical companies, clinical laboratories, universities, and hospitals. Founded in 1952, Bio-Rad has its operating units in several countries, including those in the Middle East and Africa.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTE PRODUCTS

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET

2.3. MARKET ATTRACTIVENESS INDEX

2.4. VENDOR LANDSCAPE

2.5. KEY INSIGHTS

2.6. KEY DRIVERS

2.6.1. PROLIFERATING BURDEN OF CHRONIC DISEASES

2.6.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS

2.7. KEY RESTRAINTS

2.7.1. SECURITY RISKS ASSOCIATED WITH DIGITAL GENOME

2.7.2. LACK OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY

2.8. KEY OPPORTUNITIES

2.8.1. TECHNOLOGICAL ADVANCEMENTS

2.8.2. PREVAILING AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES

3.    DIGITAL GENOME MARKET OUTLOOK - BY PRODUCT

3.1. SEQUENCING AND ANALYZER INSTRUMENTS

3.2. DNA/RNA ANALYSIS

3.3. SEQUENCING AND ANALYSIS SOFTWARE

3.4. SEQUENCING CHIPS

3.5. SAMPLE PREP INSTRUMENTS

4.    DIGITAL GENOME MARKET OUTLOOK - BY APPLICATION

4.1. DIAGNOSTICS

4.2. DRUG DISCOVERY

4.3. ACADEMIC RESEARCH

4.4. PERSONALIZED MEDICINE

4.5. AGRICULTURAL

4.6. OTHER APPLICATIONS

5.    DIGITAL GENOME MARKET OUTLOOK - BY END-USER

5.1. DIAGNOSTICS AND FORENSIC LABS

5.2. ACADEMIC RESEARCH INSTITUTES

5.3. HOSPITALS

5.4. OTHER END-USERS

6.    DIGITAL GENOME MARKET - MIDDLE EAST AND AFRICA

6.1. COUNTRY ANALYSIS

6.1.1. SAUDI ARABIA

6.1.2. UNITED ARAB EMIRATES

6.1.3. TURKEY

6.1.4. SOUTH AFRICA

6.1.5. REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILE

7.1. QIAGEN NV

7.2. OXFORD NANOPORE TECHNOLOGIES LTD

7.3. BECTON, DICKINSON, AND COMPANY (BD)

7.4. ILLUMINA INC

7.5. THERMO FISHER SCIENTIFIC INC

7.6. PACIFIC BIOSCIENCE

7.7. BIO-RAD LABORATORIES INC

7.8. F. HOFFMANN-LA ROCHE

7.9. PERKINELMER INC

7.10. REGENERON PHARMACEUTICALS

7.11. BIOMERIEUX SA

7.12. ABBOTT LABORATORIES

7.13. AGILENT TECHNOLOGIES INC.

7.14. INSCRIPTA

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR LANDSCAPE

TABLE 3:       MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 4:       MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 5:       MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 6:       MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 3:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 4:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)

FIGURE 6:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 8:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 9:     MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 10:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 11:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)

FIGURE 12:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 13:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)

FIGURE 14:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 15:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 16:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 17:  MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 18:  SAUDI ARABIA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 19:  UNITED ARAB EMIRATES DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  TURKEY DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  SOUTH AFRICA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  REST OF MIDDLE EAST & AFRICA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;